In March 2025, the company announced new options for any direct-to-client presenting of its Wegovy weight loss drug. The company set up a completely new pharmacy, referred to as NovoCare, which might cost buyers $499 a month for access to the drug, below fifty percent the price of the drug via other pharmaceutical distribution networks.[53]Particul